Active Ingredient: ALOGLIPTIN BENZOATE; METFORMIN HYDROCHLORIDE
Proprietary Name: KAZANO
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 12.5MG BASE;500MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N203414
Product Number: 001
Approval Date: Jan 25, 2013
Applicant Holder Full Name: TAKEDA PHARMACEUTICALS USA INC
Marketing Status:
Prescription
Patent and Exclusivity Information
